- Home
- CRIS vs NUKK Comparison
CRIS vs NUKK Comparison
Compare CRIS & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- NUKK
- Stock Information
- Founded
- CRIS 2000
- NUKK 2013
- Country
- CRIS United States
- NUKK United States
- Employees
- CRIS N/A
- NUKK N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- NUKK Blank Checks
- Sector
- CRIS Health Care
- NUKK Finance
- Exchange
- CRIS Nasdaq
- NUKK Nasdaq
- Market Cap
- CRIS 22.9M
- NUKK 25.4M
- IPO Year
- CRIS 2000
- NUKK N/A
- Fundamental
- Price
- CRIS $1.71
- NUKK $4.20
- Analyst Decision
- CRIS Strong Buy
- NUKK
- Analyst Count
- CRIS 2
- NUKK 0
- Target Price
- CRIS $16.50
- NUKK N/A
- AVG Volume (30 Days)
- CRIS 70.9K
- NUKK 276.5K
- Earning Date
- CRIS 08-05-2025
- NUKK 08-14-2025
- Dividend Yield
- CRIS N/A
- NUKK N/A
- EPS Growth
- CRIS N/A
- NUKK N/A
- EPS
- CRIS N/A
- NUKK N/A
- Revenue
- CRIS $11,405,000.00
- NUKK N/A
- Revenue This Year
- CRIS N/A
- NUKK N/A
- Revenue Next Year
- CRIS $9.52
- NUKK N/A
- P/E Ratio
- CRIS N/A
- NUKK N/A
- Revenue Growth
- CRIS 12.24
- NUKK N/A
- 52 Week Low
- CRIS $1.02
- NUKK $1.30
- 52 Week High
- CRIS $8.29
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- CRIS 48.40
- NUKK 32.56
- Support Level
- CRIS $1.47
- NUKK $3.31
- Resistance Level
- CRIS $1.79
- NUKK $4.59
- Average True Range (ATR)
- CRIS 0.14
- NUKK 0.54
- MACD
- CRIS 0.01
- NUKK 0.09
- Stochastic Oscillator
- CRIS 57.32
- NUKK 30.27
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).